DFNB9
Clinical trials for DFNB9 explained in plain language.
Never miss a new study
Get alerted when new DFNB9 trials appear
Sign up with your email to follow new studies for DFNB9, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a gene therapy restore natural hearing after cochlear implants?
⭐️ CURE ⭐️ OngoingThis trial tests an experimental gene therapy called EA0010 in children aged 1 to 17 with hearing loss caused by mutations in the OTOF gene, who already have cochlear implants. The therapy is injected into one ear and aims to deliver a working copy of the OTOF gene to inner ear c…
Matched conditions: DFNB9
Phase: NA • Sponsor: Shanghai EmayGene Technology Co., Ltd • Aim: ⭐️ CURE ⭐️
Last updated Aug 14, 2026 00:00 UTC
-
One-Time injection aims to restore hearing in children born deaf
⭐️ CURE ⭐️ OngoingThis trial tests a gene therapy called SENS-501 for children aged 6 to 31 months who are severely or profoundly deaf due to mutations in the otoferlin gene. The therapy is injected directly into one inner ear to deliver a working copy of the gene. The goal is to restore natural h…
Matched conditions: DFNB9
Phase: PHASE1, PHASE2 • Sponsor: Sensorion • Aim: ⭐️ CURE ⭐️
Last updated Jul 10, 2026 00:00 UTC